Aquablation therapy
Aquablation therapy is a surgical procedure for men with lower urinary tract symptoms resulting from benign prostatic hyperplasia. It is in the early stages of study. It is not categorized as minimally invasive as general anesthesia is required. The procedure was developed by PROCEPT BioRobotics and combines real-time visualization through a cystoscope and a bi-plane ultrasound, while using a high-velocity sterile saline heat-free waterjet and autonomous robotics to remove prostate tissue.
Reviews from 2018 and 2019 found aquablation to be probably as effective as transurethral resection of the prostate with shorter operation times. Aquablation may be successful in large volume prostates and in those with middle lobes protruding into the bladder.
